Related references
Note: Only part of the references are listed.Cytotoxic human peripheral blood-derived γδT cells kill glioblastoma cell lines: implications for cell-based immunotherapy for patients with glioblastoma
Tsutomu Nakazawa et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
被撤回的出版物: Enhanced Anti-Tumor Effect of Zoledronic Acid Combined with Temozolomide against Human Malignant Glioma Cell Expressing O6-Methylguanine DNA Methyltransferase (Retracted article. See vol. 17, 2022)
Junya Fukai et al.
PLOS ONE (2014)
Nitrogen-containing bisphosphonates induce apoptosis of hematopoietic tumor cells via inhibition of Ras signaling pathways and Bim-mediated activation of the intrinsic apoptotic pathway
Masanobu Tsubaki et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Human Vγ9Vδ2 T Cells Specifically Recognize and Kill Acute Myeloid Leukemic Blasts
Julie Gertner-Dardenne et al.
JOURNAL OF IMMUNOLOGY (2012)
Charting the course across the blood-brain barrier
David Nathanson et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Preclinical evaluation of ex vivo expanded/activated gamma delta T cells for immunotherapy of glioblastoma multiforme
Nichole L. Bryant et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Gene expression profiling predicts response to temozolomide in malignant gliomas
Atsuo Yoshino et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2010)
γδ T cell effector functions: a blend of innate programming and acquired plasticity
Marc Bonneville et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Novel cell death by downregulation of eEF1A1 expression in tetraploids
Y. Kobayashi et al.
CELL DEATH AND DIFFERENTIATION (2009)
Efficient Killing of Human Colon Cancer Stem Cells by gamma delta T Lymphocytes
Matilde Todaro et al.
JOURNAL OF IMMUNOLOGY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Characterization and immunotherapeutic potential of γδ T-cells in patients with glioblastoma
Nichole L. Bryant et al.
NEURO-ONCOLOGY (2009)
Apoptosis: controlled demolition at the cellular level
Rebecca C. Taylor et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Induction of mitochondria-dependent apoptosis through the inhibition of mevalonate pathway in human breast cancer cells by YM529, a new third generation bisphosphonate
Hiroo Nakajima et al.
CANCER LETTERS (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Perspectives of gamma delta T cells in tumor immunology
Dieter Kabelitz et al.
CANCER RESEARCH (2007)
Inhibition of protein prenylation by bisphosphonates causes sustained activation of Rac, Cdc42, and Rho GTPases
JE Dunford et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2Rγnull mice engrafted with mobilized human hemopoietic stem cells
LD Shultz et al.
JOURNAL OF IMMUNOLOGY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Caspase inhibition switches doxorubicin-induced apoptosis to senescence
A Rebbaa et al.
ONCOGENE (2003)
Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells
HJ Gober et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
NOD/SCID/γcnull mouse:: an excellent recipient mouse model for engraftment of human cells
M Ito et al.
BLOOD (2002)
Pan-caspase inhibitor zVAD enhances cell death in RAW246.7 macrophages
SO Kim et al.
JOURNAL OF ENDOTOXIN RESEARCH (2001)
Share Paper
